Adomeglivant

Description: Adomeglivant, also known as LY2409021, is a potent and selective glucagon receptor antagonist. LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. Blockade of glucagon signalling in patients with type 2 diabetes is well tolerated and results in substantial reduction of fasting and postprandial glucose with minimal hypoglycaemia, but with reversible increases in aminotransferases. Inhibition of glucagon signalling by LY2409021 is a promising potential treatment for patients with type 2 diabetes and should be evaluated in longer clinical trials to better evaluate benefits and risks.

Name: Adomeglivant
CAS#: 1488363-78-5 (S-isomer)
Chemical Formula: C32H36F3NO4
Exact Mass: 555.2596
Molecular Weight: 555.64
Elemental Analysis: C, 69.17; H, 6.53; F, 10.26; N, 2.52; O, 11.52

Synonym: LY2409021; LY-2409021; LY 2409021; Adomeglivant

IUPAC/Chemical Name: 3-(4-{(1S)-1-[(4'-tert-butyl-2,6-dimethylbiphenyl-4-yl)oxy]-4,4,4-trifluorobutyl}benzamido)propanoic acid

InChi Key: FASLTMSUPQDLIB-MHZLTWQESA-N

InChi Code: InChI=1S/C32H36F3NO4/c1-20-18-26(19-21(2)29(20)23-10-12-25(13-11-23)31(3,4)5)40-27(14-16-32(33,34)35)22-6-8-24(9-7-22)30(39)36-17-15-28(37)38/h6-13,18-19,27H,14-17H2,1-5H3,(H,36,39)(H,37,38)/t27-/m0/s1

SMILES Code: O=C(O)CCNC(C1=CC=C([C@@H](OC2=CC(C)=C(C3=CC=C(C(C)(C)C)C=C3)C(C)=C2)CCC(F)(F)F)C=C1)=O

Appearance: White to off-white solid powder.